Cambridge Healthtech Institue’s 4th Annual Optimizing Bioassays for Biologics

The discovery and development of emerging therapies such as bispecifics, antibody-drug conjugates, biosimilars, and cell/gene therapies has raised the bar for bioassay scientists. There are numerous considerations to keep in mind during bioassay development, ranging from statistics to life cycle management. At the Fourth Annual Optimizing Bioassays for Biologics, bioassay experts will address the top challenges in bioassay design including novel technologies, increasing complex mechanisms-of-action, regulation, and the application of statistics in assay development. Case studies and best practices for handling the most common issues in biological assay design will be presented. Overall, this event will showcase ways to continue moving a biologic forward in the discovery pipeline.